{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:14:41Z","timestamp":1761059681049},"reference-count":38,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Cytopathology"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:p>GATA binding protein 3 is a zinc finger transcription factor with high affinity for urothelial tissue and is a promising immunohistochemical marker in detection of urothelial carcinomas (UC). We studied its usefulness in metastatic high\u2010grade UC. This study was performed on cell blocks (CB) of fine needle aspirates from 25 cases of metastatic high\u2010grade UC in patients with previously resected high\u2010grade UC. Immunohistochemical staining for GATA3, thrombomodulin, uroplakin, cytokeratin 7, and cytokeratin 20 was performed. Twenty\u2010three of 25 cases of metastatic UC expressed GATA3 (92%); positive staining for cytokeratin 7 was present in 23 of 25 cases (92%), 20 of 25 (80%) stained for thrombomodulin, and 13 of 25 (52%) stained for cytokeratin 20. No case expressed uroplakin. Five hundred forty\u2010seven non\u2010urothelial carcinomas, including breast ductal carcinoma (77), hepatocellular carcinoma (100), colonic adenocarcinoma (81), pancreatic adenocarcinoma (28), gastric adenocarcinoma (31), endometrial carcinoma (27), ovarian serous carcinoma (27), lung adenocarcinoma (27), lung squamous cell carcinoma (26), malignant melanoma (27), renal cell carcinoma (48), and prostatic adenocarcinoma (48) in tissue microarrays were also analyzed and were GATA3 negative except for 35 of 77 (45.5%) of GATA3 positive breast ductal carcinoma. GATA3 has high sensitivity and specificity for detection of metastatic UC and thus may play an important role in diagnosing metastatic UC in CB samples. Diagn. Cytopathol. 2014;42:809\u2013815. \u00a9 2014 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/dc.23131","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T05:40:40Z","timestamp":1393566040000},"page":"809-815","source":"Crossref","is-referenced-by-count":16,"title":["GATA3 expression in metastatic urothelial carcinoma in fine needle aspiration cell blocks: A review of 25 cases"],"prefix":"10.1002","volume":"42","author":[{"given":"Momin T.","family":"Siddiqui","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Emory University Hospital Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabnam","family":"Seydafkan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Emory University Hospital Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Emory University Hospital Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"SocietyAC.Cancer facts and figures. Atlanta GA;2013. Available at:http:\/\/www.cancer.org."},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11289"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21668"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.43.6.348"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(79)80097-0"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196412)17:12<1533::AID-CNCR2820171205>3.0.CO;2-7"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(80)90067-9"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910315)67:6<1525::AID-CNCR2820670611>3.0.CO;2-8"},{"key":"e_1_2_5_10_1","first-page":"524","article-title":"Pathology of bladder cancer: Assessment of prognostic variables and response to therapy","volume":"17","author":"Reuter VE","year":"1990","journal-title":"Semin Oncol"},{"issue":"7","key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.1980.45.s7.1823","article-title":"The pathology of human bladder cancer","volume":"45","author":"Friedell GH","year":"1980","journal-title":"Cancer"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318260cde7"},{"key":"e_1_2_5_13_1","first-page":"431","article-title":"The pathogenesis of bladder cancer","volume":"89","author":"Friedell GH","year":"1977","journal-title":"Am. J Pathol"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200301000-00001"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911404223"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2672"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3182a28a68"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181908e24"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/110.3.385"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.42.3.250"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2011-0575-OA"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.5036"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000030361"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91595-D"},{"key":"e_1_2_5_25_1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.5858\/2006-130-844-DPOBCP","article-title":"Dual\u2010track pathway of bladder carcinogenesis: Practical implications","volume":"130","author":"Spiess PE","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_5_26_1","first-page":"5501","article-title":"Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder","volume":"9","author":"Koga F","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880175"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31802f5d33"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01560.x"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ"},{"key":"e_1_2_5_31_1","first-page":"33","article-title":"The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung","volume":"102","author":"Raspollini MR","year":"2010","journal-title":"Pathologica"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.02.011"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1996.d01-500.x"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/35.11.2821107"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.2.329.329"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1997.3040892.x"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1309\/PYQC-17CB-063T-Q07J"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.11.128"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213281.43036.bb"}],"container-title":["Diagnostic Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdc.23131","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dc.23131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T22:39:11Z","timestamp":1696545551000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dc.23131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1002\/dc.23131"],"URL":"https:\/\/doi.org\/10.1002\/dc.23131","archive":["Portico"],"relation":{},"ISSN":["8755-1039","1097-0339"],"issn-type":[{"value":"8755-1039","type":"print"},{"value":"1097-0339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}